These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 37589877)
21. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
22. Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. Wang W; Liu Y; Wang Z; Tan X; Jian X; Zhang Z Sci Rep; 2024 Sep; 14(1):22251. PubMed ID: 39333335 [TBL] [Abstract][Full Text] [Related]
23. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
24. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
25. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma. Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538 [TBL] [Abstract][Full Text] [Related]
26. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma. Cheng X; Wei Y; Fu Y; Li J; Han L Front Immunol; 2022; 13():1052182. PubMed ID: 36532007 [TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
28. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Jiang C; Liu Y; Wen S; Xu C; Gu L Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186 [TBL] [Abstract][Full Text] [Related]
29. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes. Luo Q; Zhou P; Chang S; Huang Z; Zeng X Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674 [TBL] [Abstract][Full Text] [Related]
30. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
31. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes. Ren Y; He S; Feng S; Yang W Front Public Health; 2022; 10():916364. PubMed ID: 35712285 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of Gene Expression Profiles Identifies a Chen Z; Chen M; Xue Z; Zhu X Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234 [No Abstract] [Full Text] [Related]
33. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related]
34. INHBA is a prognostic predictor for patients with colon adenocarcinoma. Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338 [TBL] [Abstract][Full Text] [Related]
35. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132 [TBL] [Abstract][Full Text] [Related]
36. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition. Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013 [TBL] [Abstract][Full Text] [Related]
37. Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases. Tang Y; Guo H; Chen L; Wang X; Chen Q; Gou L; Liu X; Wang X PLoS One; 2023; 18(4):e0284089. PubMed ID: 37023088 [TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
39. A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation. Dong W; Zhang H; Li Q; Guan N; Yun C; Zhao H; Zhang F; Zeng Z; Hu Y; Li Q; Yang J; Ma Z; Chen M; Xiao W Eur J Cancer Prev; 2023 Nov; 32(6):557-565. PubMed ID: 37310401 [TBL] [Abstract][Full Text] [Related]
40. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]